IR Licensing and Partnerships

Latest News

June 12th 2025

GSK Licenses altSonflex1-2-3 Shigella Vaccine to Bharat Biotech

Under terms of the deal, Bharat Biotech will lead late-stage development and scale-up of the altSonflex1-2-3 Shigella vaccine for potential distribution in low- and middle-income countries.

February 13th 2025

Novartis Strikes Deal to Acquire Anthos Therapeutics

By Don Tracy, Associate Editor

February 12th 2025

Abcuro Secures $200 Million in Series C Funding to Advance Ulviprubart for Inclusion Body Myositis

By Don Tracy, Associate Editor

January 30th 2025

ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer

By Don Tracy, Associate Editor

IR Licensing and Partnerships

Latest News

Trending on PharmExec

The Agentic AI Revolution in Biopharma

How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications

Novartis Investors Share Concerns Over M&A Strategy: Report

Artisan Partners’ Director Calls for Novartis Board Shake-Up

Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum